Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration

Figure 2

PSA course of a hormone-refractory prostate cancer patient whose PSA declined due to surgical castration. ▵: surgical castration, CMA: chlormadinone acetate, vertical line: PSA (ng/mL), horizontal line: date. Before surgical castration, dose of docetaxel every other week was 35 mg/m² per course.